Investment
Features
FeesSafety
Academy
More
Pluang+

Renegade Gold reports high-grade gold assays and visible gold at Belanger project, expanding mineralized zones.

Market News
05 Oct 2026
Newsfile Corp
View Source
Bullish
Renegade Gold reports high-grade gold assays and visible gold at Belanger project, expanding mineralized zones.

Renegade Gold Inc. announced new high-grade gold assay results from its 100%-owned Belanger project in Ontario, including samples with up to 25.9 g/t gold and visible gold in outcrop. The 2026 exploration program extended the known mineralized zone by over 60 meters along strike and identified multiple new zones of gold mineralization. Additional soil and till sampling at the LP-Uchi corridor and mapping at the BobJo project are complete, with results pending. These findings support advancing the projects toward drill-ready status for the planned 2026 drilling program, highlighting the potential for a broader high-grade gold system in the area.

Renegade Gold reports high-grade mineralization at its Belanger project. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 05, 2026 17:42 WIB: 22 of 38 US stocks rose and 15 fell. Notable prices include ICL at USD 5.07 (+0.60%), AU at USD 95.48 (+0.59%), and AEM at USD 184.75 (+0.58%).

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
57 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
57 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
57 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
57 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
57 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App